Salts of heterocyclic modulators of HIF activity for treatment of disease
US9663504B2 · kind B2 · utility
6Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2015 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Feb 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to salts of heterocyclic compounds and methods that inhibit HIF pathway activity. The compounds are designed to treat or prevent cancer and other hypoxia-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.